Identifying Potential Tumor Markers and Antigens by Database Mining and Rapid Expression Screening

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

Figure 2.
Figure 2.

Fluorescent-PCR verification of a candidate glioblastoma marker, GPNMB. (A) Template cDNA from a bulk glioblastoma (GBM 861) and matched glioma/normal tissue pairs (GS1099/Cortex1099 and AA1100/Cortex1100) were amplified with primers specific for GPNMB. (B) Melting curve analysis is performed simultaneously to optimize detection temperature, revealing a single peak consistent with a single amplification product. (C) After fluorescent-PCR, all reaction products were visualized on an agarose gel to verify a single product of the correct size. (D) Northern blot of normal fetal brain and three established GBM cell lines also show a difference in expression forGPNMB.

This Article

  1. Genome Res. 10: 1393-1402

Preprint Server